首页 > 最新文献

Open Rheumatology Journal最新文献

英文 中文
Clinical Features, Socio-cultural Characteristics, Sleep Patterns, and Depression in Fibromyalgia Patients from India: A Cross-Sectional Study 印度纤维肌痛患者的临床特征、社会文化特征、睡眠模式和抑郁:一项横断面研究
Q4 Medicine Pub Date : 2023-10-25 DOI: 10.2174/0118743129267713231006113813
Smruti Ramteke, Sanjay Ramteke, Sandeep Yadav, Nitin Chandak
Fibromyalgia (FM) is a complex and chronic disease with significant regional variation. There is a lack of studies on Fibromyalgia (FM) in Indian population. The aim of this study is to investigate the clinical features of FM patients in India, including the prevalence and distribution of comorbidities, sleep patterns, and depression. Cross-sectional analysis of patients attending outpatient rheumatology clinic from 2019-2020 fell in the ACR2016 criteria for FM. Of the 121 patients enrolled in the study, the majority (93.4%) were female, with a female-to-male ratio of 14:1. The mean age of the patients was 45 ±11 years. The socio-cultural profile of the patients revealed that the majority were married (88%) and homemakers (68.8%), lived in nuclear families (56%) and were middle to upper middle class (68.6%). Contrary to the existing literature, a higher prevalence of FM has been observed in people with a higher educational status. Common clinical symptoms were extensive body aches (100%), fatigue (88%), difficulty concentrating (69.4%), irritability and gastrointestinal complaints (58.5%). We observed a high prevalence of primary headache (76%), mainly migraine (42%) and obsessive-compulsive (OCB) (71%). Sleep disturbances and depression were found in the significant number of patients with FM. The patients reported various sleep problems, such as snoring, waking up at night, daytime sleepiness, and taking daytime naps. Most of the patients had mild (50.8%) to moderate (29%) depression, while a smaller proportion experienced severe (6.6%) symptoms. Most of the patients had low serum vitamin D (91%). The presence of moderate to severe depression was associated with the severity of FM. The demographic profile of Indian patients was similar to that reported in the literature but had varied socio-cultural profiles needing further community-based studies. The high prevalence of psychological comorbidities and sleep disturbances highlights their importance in managing FM patients.
纤维肌痛(FM)是一种复杂的慢性疾病,具有显著的区域差异。印度人群中纤维肌痛(FM)的研究缺乏。目的:本研究旨在探讨印度FM患者的临床特征,包括合并症、睡眠模式和抑郁的患病率和分布。方法:对2019-2020年在风湿病门诊就诊的符合ACR2016 FM标准的患者进行横断面分析。结果:121例入组患者中,绝大多数(93.4%)为女性,男女比例为14:1。患者平均年龄45±11岁。患者的社会文化特征显示,大多数是已婚(88%)和家庭主妇(68.8%),生活在核心家庭(56%)和中上层中产阶级(68.6%)。与现有文献相反,FM在受教育程度较高的人群中患病率更高。常见的临床症状为广泛的身体疼痛(100%)、疲劳(88%)、注意力难以集中(69.4%)、烦躁和胃肠道不适(58.5%)。我们观察到原发性头痛的患病率很高(76%),主要是偏头痛(42%)和强迫症(71%)。大量FM患者存在睡眠障碍和抑郁。患者报告了各种睡眠问题,如打鼾、夜间醒来、白天嗜睡和白天小睡。大多数患者表现为轻度(50.8%)至中度(29%)抑郁,少部分患者表现为重度(6.6%)抑郁。大多数患者血清维生素D水平较低(91%)。中度至重度抑郁症的存在与FM的严重程度相关。结论:印度患者的人口统计特征与文献报道相似,但具有不同的社会文化特征,需要进一步的社区研究。心理合并症和睡眠障碍的高患病率突出了它们在管理FM患者中的重要性。
{"title":"Clinical Features, Socio-cultural Characteristics, Sleep Patterns, and Depression in Fibromyalgia Patients from India: A Cross-Sectional Study","authors":"Smruti Ramteke, Sanjay Ramteke, Sandeep Yadav, Nitin Chandak","doi":"10.2174/0118743129267713231006113813","DOIUrl":"https://doi.org/10.2174/0118743129267713231006113813","url":null,"abstract":"Fibromyalgia (FM) is a complex and chronic disease with significant regional variation. There is a lack of studies on Fibromyalgia (FM) in Indian population. The aim of this study is to investigate the clinical features of FM patients in India, including the prevalence and distribution of comorbidities, sleep patterns, and depression. Cross-sectional analysis of patients attending outpatient rheumatology clinic from 2019-2020 fell in the ACR2016 criteria for FM. Of the 121 patients enrolled in the study, the majority (93.4%) were female, with a female-to-male ratio of 14:1. The mean age of the patients was 45 ±11 years. The socio-cultural profile of the patients revealed that the majority were married (88%) and homemakers (68.8%), lived in nuclear families (56%) and were middle to upper middle class (68.6%). Contrary to the existing literature, a higher prevalence of FM has been observed in people with a higher educational status. Common clinical symptoms were extensive body aches (100%), fatigue (88%), difficulty concentrating (69.4%), irritability and gastrointestinal complaints (58.5%). We observed a high prevalence of primary headache (76%), mainly migraine (42%) and obsessive-compulsive (OCB) (71%). Sleep disturbances and depression were found in the significant number of patients with FM. The patients reported various sleep problems, such as snoring, waking up at night, daytime sleepiness, and taking daytime naps. Most of the patients had mild (50.8%) to moderate (29%) depression, while a smaller proportion experienced severe (6.6%) symptoms. Most of the patients had low serum vitamin D (91%). The presence of moderate to severe depression was associated with the severity of FM. The demographic profile of Indian patients was similar to that reported in the literature but had varied socio-cultural profiles needing further community-based studies. The high prevalence of psychological comorbidities and sleep disturbances highlights their importance in managing FM patients.","PeriodicalId":39124,"journal":{"name":"Open Rheumatology Journal","volume":"50 3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135218975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Diagnostic Significance of Serum Sclerostin in Early Detection of Rheumatoid Arthritis in Syrian Patients 血清硬化蛋白在叙利亚类风湿关节炎早期诊断中的意义
Q4 Medicine Pub Date : 2023-10-23 DOI: 10.2174/0118743129257178231005074615
Rama Hussein, Imad Aboukhamis
Background: Rheumatoid arthritis (RA) is associated with joint deformities and local bone erosions. Sclerostin is an inhibitor of the Wnt pathway and drives to reduce bone formation. Aims: Our study aimed to compare the diagnostic significance of sclerostin with anti-CCP (anti-cyclic citrullinated peptide; normal level<20 IU/ml, and rheumatoid factor (RF; normal level<16 IU/ml) for the early diagnosis of rheumatoid arthritis in Syrian patients. Methods: This study contained fifty-eight RA patients and thirty healthy individuals who were equally age- and sex-matched. Serum sclerostin and serum anti-CCP (IgG) levels were evaluated by using the enzyme-linked immunosorbent assay (ELISA). RA activity was assessed based on disease activity scores (DAS28). Results: Our results indicated that serum levels of sclerostin levels were higher in the RA group than in the healthy group (p<0.001). There was a positive correlation between serum sclerostin and DAS28-ESR (r=0.413, p=0.001). By ROC curve, the most optimal cut-off value of sclerostin was 249.69 pg/ml (AUC was 0.910 with 95% confidence interval (CI) values (0.852-0.969), sensitivity of 87.9%, and specificity of 93.3%) [Odds Ratio (OR) and P-value: 102, P< 0.0001]. In RA patients, the sensitivity and specificity of anti-CCP were 74.1% and 90%, and 70.6% and 86.6% of RF, respectively. Conclusion: Increased serum sclerostin may aid as a new prognostic biomarker for evaluating the activity of RA. Sclerostin showed higher sensitivity and specificity than anti-CCP and RF-IgM antibodies. Therefore, sclerostin is a sensitive and specific biomarker for early diagnosis of rheumatoid arthritis.
背景:类风湿性关节炎(RA)与关节畸形和局部骨侵蚀有关。硬化蛋白是Wnt通路的一种抑制剂,并驱动减少骨形成。目的:比较硬化蛋白(sclerostin)与抗环瓜氨酸肽(anti-CCP)的诊断意义;正常水平20 IU/ml,类风湿因子(RF;正常水平(16 IU/ml)用于叙利亚患者类风湿性关节炎的早期诊断。方法:本研究包括58名RA患者和30名年龄和性别相同的健康个体。采用酶联免疫吸附试验(ELISA)测定血清硬化蛋白(sclerostin)和血清抗ccp (IgG)水平。根据疾病活动度评分(DAS28)评估RA活动性。结果:我们的研究结果表明,RA组的血清硬化素水平高于健康组(p<0.001)。血清硬化蛋白与DAS28-ESR呈正相关(r=0.413, p=0.001)。ROC曲线显示,最优截断值为249.69 pg/ml (AUC为0.910,95%可信区间(CI)为0.852 ~ 0.969),敏感性为87.9%,特异性为93.3%)[比值比(OR)和p值:102,P<0.0001]。RA患者抗ccp的敏感性和特异性分别为74.1%和90%,RF的敏感性和特异性分别为70.6%和86.6%。结论:血清硬化蛋白升高可作为评估RA活性的一种新的预后生物标志物。与抗ccp抗体和RF-IgM抗体相比,Sclerostin具有更高的敏感性和特异性。因此,硬化蛋白是类风湿关节炎早期诊断的敏感特异性生物标志物。
{"title":"The Diagnostic Significance of Serum Sclerostin in Early Detection of Rheumatoid Arthritis in Syrian Patients","authors":"Rama Hussein, Imad Aboukhamis","doi":"10.2174/0118743129257178231005074615","DOIUrl":"https://doi.org/10.2174/0118743129257178231005074615","url":null,"abstract":"Background: Rheumatoid arthritis (RA) is associated with joint deformities and local bone erosions. Sclerostin is an inhibitor of the Wnt pathway and drives to reduce bone formation. Aims: Our study aimed to compare the diagnostic significance of sclerostin with anti-CCP (anti-cyclic citrullinated peptide; normal level<20 IU/ml, and rheumatoid factor (RF; normal level<16 IU/ml) for the early diagnosis of rheumatoid arthritis in Syrian patients. Methods: This study contained fifty-eight RA patients and thirty healthy individuals who were equally age- and sex-matched. Serum sclerostin and serum anti-CCP (IgG) levels were evaluated by using the enzyme-linked immunosorbent assay (ELISA). RA activity was assessed based on disease activity scores (DAS28). Results: Our results indicated that serum levels of sclerostin levels were higher in the RA group than in the healthy group (p<0.001). There was a positive correlation between serum sclerostin and DAS28-ESR (r=0.413, p=0.001). By ROC curve, the most optimal cut-off value of sclerostin was 249.69 pg/ml (AUC was 0.910 with 95% confidence interval (CI) values (0.852-0.969), sensitivity of 87.9%, and specificity of 93.3%) [Odds Ratio (OR) and P-value: 102, P< 0.0001]. In RA patients, the sensitivity and specificity of anti-CCP were 74.1% and 90%, and 70.6% and 86.6% of RF, respectively. Conclusion: Increased serum sclerostin may aid as a new prognostic biomarker for evaluating the activity of RA. Sclerostin showed higher sensitivity and specificity than anti-CCP and RF-IgM antibodies. Therefore, sclerostin is a sensitive and specific biomarker for early diagnosis of rheumatoid arthritis.","PeriodicalId":39124,"journal":{"name":"Open Rheumatology Journal","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135461135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics of Systemic Sclerosis-associated Myopathy Patients Comparing Different Subgroups of Inflammatory Myopathies 系统性硬化症相关肌病患者的临床特征:炎性肌病不同亚组的比较
Q4 Medicine Pub Date : 2023-10-04 DOI: 10.2174/18743129-v17-e230925-2023-4
Songkiet Suwansirikul, Jirapath Intum, Chontichaporn Tejamai, Suparaporn Wangkaew
Available data regarding clinical characteristics of systemic sclerosis-associated myopathy (SSc-M) patients comparing different subgroups of muscle pathology are limited. We aimed to compare clinical and laboratory findings among different subgroups of Thai patients with SSc-M. From January 2010 to December 2019, 27 patients with suspected SSc-M underwent a muscle biopsy. Twenty-three patients with available frozen muscle biopsy specimens for repeating immunohistochemical stained for reviewing were included. There were three subgroups of pathological findings, including immune-mediated necrotizing myopathy (IMNM), non-specific myopthy (NsM), and polymyositis (PM). No fibrosing myopathy was observed. Baseline clinical data and laboratory findings were compared within those three inflammatory myopathies. Of the 23 SSc-M, there were 14 females and 19 DcSSc with a mean age and disease duration of SSc of 53.6±7.7 years and 16.4±23.6 months, respectively. Their mean duration from weakness to muscle biopsy was 3.6±6.0 months. There were 14 (60.9%) patients with IMNM, 6 (26.1%) with NsM, and 3 (13.0%) with PM. At the biopsy date, IMNM had a greater prevalence of severe muscle weakness (42.6% vs. 0% vs. 0%) and arthritis (87.5% vs. 50% vs. 0%) than the NsM and PM groups. There was no significant difference among the three inflammatory patterns regarding baseline clinical characteristics, including age, gender, SSc subtype, disease duration, other organ involvements and median values of CK and ESR levels. In this study, we found that the pathological findings of Thai SSc-M were IMNM, NsM, and PM. No fibrosing myopathy was observed. SSc with IMNM tended to have more severe baseline muscle weakness and arthritis than the other inflammatory patterns.
背景:关于系统性硬化症相关肌病(SSc-M)患者临床特征比较不同肌肉病理亚组的现有数据有限。我们的目的是比较泰国SSc-M患者不同亚组的临床和实验室结果。方法:2010年1月至2019年12月,27例疑似SSc-M患者进行了肌肉活检。23例可获得的冷冻肌肉活检标本用于重复免疫组织化学染色以进行回顾。病理结果分为三个亚组,包括免疫介导的坏死性肌病(IMNM)、非特异性肌病(NsM)和多发性肌炎(PM)。未见纤维化肌病。对这三种炎症性肌病的基线临床资料和实验室结果进行比较。结果:23例SSc- m中,女性14例,DcSSc 19例,SSc平均年龄53.6±7.7岁,病程16.4±23.6个月。从虚弱到肌肉活检的平均时间为3.6±6.0个月。IMNM 14例(60.9%),NsM 6例(26.1%),PM 3例(13.0%)。在活检日期,IMNM有更大的严重肌肉无力的患病率(42.6%比。0% vs。0%)和关节炎(87.5% vs。50% vs。0%)高于NsM和PM组。三种炎症模式在基线临床特征方面无显著差异,包括年龄、性别、SSc亚型、病程、其他器官受累以及CK和ESR水平的中值。结论:在本研究中,我们发现泰国SSc-M的病理表现为IMNM、NsM和PM。未见纤维化肌病。伴有IMNM的SSc倾向于比其他炎症模式更严重的基线肌无力和关节炎。
{"title":"Clinical Characteristics of Systemic Sclerosis-associated Myopathy Patients Comparing Different Subgroups of Inflammatory Myopathies","authors":"Songkiet Suwansirikul, Jirapath Intum, Chontichaporn Tejamai, Suparaporn Wangkaew","doi":"10.2174/18743129-v17-e230925-2023-4","DOIUrl":"https://doi.org/10.2174/18743129-v17-e230925-2023-4","url":null,"abstract":"Available data regarding clinical characteristics of systemic sclerosis-associated myopathy (SSc-M) patients comparing different subgroups of muscle pathology are limited. We aimed to compare clinical and laboratory findings among different subgroups of Thai patients with SSc-M.\u0000 \u0000 \u0000 \u0000 From January 2010 to December 2019, 27 patients with suspected SSc-M underwent a muscle biopsy. Twenty-three patients with available frozen muscle biopsy specimens for repeating immunohistochemical stained for reviewing were included. There were three subgroups of pathological findings, including immune-mediated necrotizing myopathy (IMNM), non-specific myopthy (NsM), and polymyositis (PM). No fibrosing myopathy was observed. Baseline clinical data and laboratory findings were compared within those three inflammatory myopathies.\u0000 \u0000 \u0000 \u0000 Of the 23 SSc-M, there were 14 females and 19 DcSSc with a mean age and disease duration of SSc of 53.6±7.7 years and 16.4±23.6 months, respectively. Their mean duration from weakness to muscle biopsy was 3.6±6.0 months. There were 14 (60.9%) patients with IMNM, 6 (26.1%) with NsM, and 3 (13.0%) with PM. At the biopsy date, IMNM had a greater prevalence of severe muscle weakness (42.6% vs. 0% vs. 0%) and arthritis (87.5% vs. 50% vs. 0%) than the NsM and PM groups. There was no significant difference among the three inflammatory patterns regarding baseline clinical characteristics, including age, gender, SSc subtype, disease duration, other organ involvements and median values of CK and ESR levels.\u0000 \u0000 \u0000 \u0000 In this study, we found that the pathological findings of Thai SSc-M were IMNM, NsM, and PM. No fibrosing myopathy was observed. SSc with IMNM tended to have more severe baseline muscle weakness and arthritis than the other inflammatory patterns.","PeriodicalId":39124,"journal":{"name":"Open Rheumatology Journal","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135647600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Interleukin-6 and Tumor Necrosis Factor-alpha Gene Polymorphisms with Gnetic Susceptibility of Psoriatic Arthritis in Kuwaiti Arab Patients 白细胞介素-6和肿瘤坏死因子- α基因多态性与科威特阿拉伯患者银屑病关节炎遗传易感性的关系
Q4 Medicine Pub Date : 2023-09-11 DOI: 10.2174/18743129-v17-e230714-2023-2
Adel M. Al-Awadhi, Mohammad Z. Haider, Aminah M. Al-Awadi, Anita K. Kalarikkal, Jalaja Sukumaran, Eman AH Hasan, Youssef A. Bartella
Background: Psoriatic arthritis (PsA) is an inflammatory arthritic disease in which joint inflammation occurs with psoriasis. It results from a complex interplay between genetic, immunological and environmental factors. In PsA, the activation of T cells is considered as a crucial step in the disease process. The T-lymphocytes affect the proliferation of epidermal skin cells and result in abnormal differentiation. Altered cytokine networks have been shown to play a central role in the pathogenesis of PsA. Psoriasis is characterized by Th-1 type cytokine pattern in which there is a marked variation in the secretion of interleukin-6 (IL6), interleukin-13 (IL13) and Tumor necrosis factor-alpha (TNF-alpha). This study investigated the association of IL6 , IL13 and TNF - alpha gene polymorphisms with genetic susceptibility of PsA in Kuwaiti patients. Methods: The genotypes of IL6 gene (-174G/C; rs1800795), IL13 gene (R130Q; rs20541) and TNF-alpha gene (-308A/G’ rs1800629) polymorphisms were detected in 113 Kuwaiti PsA patients and were compared to that in 104 healthy controls. The PsA patients were diagnosed on the basis of the presence of inflammatory arthritis with psoriasis with no rheumatoid factor in the serum. The genotypes for IL6 , IL13 and TNF-alpha gene polymorphisms were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methods and were confirmed by DNA sequencing. Results: The frequency of IL6 gene (-174G/C; rs1800795) and TNF-alpha gene (-308A/G’ rs1800629) polymorphisms manifested a statistically significant difference between Kuwaiti PsA patients and controls. However, the frequency of IL13 gene (R130Q; rs20541) polymorphism did not show a significant difference between Kuwaiti PsA patients and the controls. Conclusion: Our data show an association of two cytokine gene polymorphisms in IL6 gene (-174G/C; rs1800795) and TNF-alpha gene (-308A/G’ rs1800629) with PsA in Kuwaiti patients highlighting their significant contribution to genetic susceptibility of this chronic disease possibly along with other factors.
背景:银屑病关节炎(Psoriatic arthritis, PsA)是一种伴有银屑病的关节炎症的炎性关节炎疾病。它是遗传、免疫和环境因素复杂相互作用的结果。在PsA中,T细胞的激活被认为是疾病过程中的关键步骤。t淋巴细胞影响表皮皮肤细胞的增殖并导致异常分化。细胞因子网络的改变已被证明在PsA的发病机制中起核心作用。银屑病以Th-1型细胞因子模式为特征,其中白细胞介素-6 (IL6)、白细胞介素-13 (IL13)和肿瘤坏死因子- α (tnf - α)的分泌有明显变化。本研究探讨了科威特患者中il - 6、il - 13和TNF - α基因多态性与PsA遗传易感性的关系。方法:il - 6基因分型(-174G/C;rs1800795), IL13基因(R130Q;在113名科威特PsA患者中检测到rs20541)和tnf - α基因(-308A/G ' rs1800629)多态性,并与104名健康对照进行比较。PsA患者在血清中无类风湿因子的基础上诊断为银屑病炎症性关节炎。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法确定IL6、IL13和tnf - α基因多态性的基因型,并进行DNA测序。结果:il - 6基因频率为-174G/C;rs1800795)和tnf - α基因(-308A/G ' rs1800629)多态性在科威特PsA患者与对照组之间存在统计学差异。然而,IL13基因(R130Q;rs20541)多态性在科威特PsA患者和对照组之间没有显着差异。结论:我们的数据显示两种细胞因子基因多态性在il - 6基因(-174G/C;rs1800795)和tnf - α基因(-308A/G ' rs1800629)在科威特患者中与PsA相关,突出了它们可能与其他因素一起对这种慢性疾病的遗传易感性有重要贡献。
{"title":"Association of Interleukin-6 and Tumor Necrosis Factor-alpha Gene Polymorphisms with Gnetic Susceptibility of Psoriatic Arthritis in Kuwaiti Arab Patients","authors":"Adel M. Al-Awadhi, Mohammad Z. Haider, Aminah M. Al-Awadi, Anita K. Kalarikkal, Jalaja Sukumaran, Eman AH Hasan, Youssef A. Bartella","doi":"10.2174/18743129-v17-e230714-2023-2","DOIUrl":"https://doi.org/10.2174/18743129-v17-e230714-2023-2","url":null,"abstract":"Background: Psoriatic arthritis (PsA) is an inflammatory arthritic disease in which joint inflammation occurs with psoriasis. It results from a complex interplay between genetic, immunological and environmental factors. In PsA, the activation of T cells is considered as a crucial step in the disease process. The T-lymphocytes affect the proliferation of epidermal skin cells and result in abnormal differentiation. Altered cytokine networks have been shown to play a central role in the pathogenesis of PsA. Psoriasis is characterized by Th-1 type cytokine pattern in which there is a marked variation in the secretion of interleukin-6 (IL6), interleukin-13 (IL13) and Tumor necrosis factor-alpha (TNF-alpha). This study investigated the association of IL6 , IL13 and TNF - alpha gene polymorphisms with genetic susceptibility of PsA in Kuwaiti patients. Methods: The genotypes of IL6 gene (-174G/C; rs1800795), IL13 gene (R130Q; rs20541) and TNF-alpha gene (-308A/G’ rs1800629) polymorphisms were detected in 113 Kuwaiti PsA patients and were compared to that in 104 healthy controls. The PsA patients were diagnosed on the basis of the presence of inflammatory arthritis with psoriasis with no rheumatoid factor in the serum. The genotypes for IL6 , IL13 and TNF-alpha gene polymorphisms were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methods and were confirmed by DNA sequencing. Results: The frequency of IL6 gene (-174G/C; rs1800795) and TNF-alpha gene (-308A/G’ rs1800629) polymorphisms manifested a statistically significant difference between Kuwaiti PsA patients and controls. However, the frequency of IL13 gene (R130Q; rs20541) polymorphism did not show a significant difference between Kuwaiti PsA patients and the controls. Conclusion: Our data show an association of two cytokine gene polymorphisms in IL6 gene (-174G/C; rs1800795) and TNF-alpha gene (-308A/G’ rs1800629) with PsA in Kuwaiti patients highlighting their significant contribution to genetic susceptibility of this chronic disease possibly along with other factors.","PeriodicalId":39124,"journal":{"name":"Open Rheumatology Journal","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136070912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Etiopathogenesis and Genetic Factors in Idiopathic Inflammatory Myopathies: A Review Article 特发性炎性肌病的发病机制及遗传因素综述
Q4 Medicine Pub Date : 2023-04-05 DOI: 10.2174/18743129-v17-e230327-2022-11
Gustavo-Esteban Lugo-Zamudio, Rosa-Elda Barbosa-Cobos, Lucía-Verónica Maya-Piña, Dolores Delgado-Ochoa, María-Mercedes López-Mayorga, Ivonne Arenas-Silva, Diana-Sarai Arellano-Álvarez
Introduction: Idiopathic inflammatory myopathies (IIM) are a group of heterogeneous systemic autoimmune diseases characterized by muscle inflammation from unknown causes resulting in chronic weakness. Recent studies have shown the role of the cellular immune response affecting muscle fibers in polymyositis (PM), inclusion body myositis, and to a lesser extent, dermatomyositis (DM), wherein humoral immunity is more involved. The value of genetic factors of the class II major histocompatibility complex (MHC II) has also been highlighted. In studies of murine models, the presence of HLA-DR3 favors a higher risk of developing inflammatory muscle disease, including PM and juvenile DM. In recent years, few studies have provided timely information regarding this, thus the researchers initially proposed a review of existing literature to broaden the context regarding what was described and to visualize proposals that may enhance the understanding of this group of inflammatory pathologies. Methods: The design, implementation, analysis, and reporting of this study were followed according to the search with MeSH terms (Autoimmune myopathy, Inflammatory myopathies, Idiopathic inflammatory myopathies AND Major histocompatibility complex and genetics). We analyzed 12 articles for this review article. Conclusion: In the etiopathogenesis of IIM, both humoral and cellular immunity are observed, considering the presence of a trigger that causes the immune response. As for the immunogenetics, this review highlights what has been reported in Chinese and Mexican populations, where HLADRB1*09:01 is related to the presence of DM, and is observed as the first variant identified in various populations. This increases interest in this allele in the particular case to study DM and strengthens research that proposes the study of IIM independently for each nosological entity.
特发性炎症性肌病(IIM)是一组异质性系统性自身免疫性疾病,其特征是未知原因的肌肉炎症导致慢性无力。最近的研究表明,细胞免疫反应在多发性肌炎(PM)、包涵体肌炎以及较小程度的皮肌炎(DM)中影响肌纤维的作用,其中体液免疫更多地参与。II类主要组织相容性复合体(MHC II)的遗传因素的价值也被强调。在对小鼠模型的研究中,HLA-DR3的存在增加了发生炎性肌肉疾病的风险,包括PM和幼年型DM。近年来,很少有研究提供了关于这方面的及时信息,因此研究人员最初提出了对现有文献的回顾,以扩大所描述的背景,并提出可视化的建议,以增强对这组炎症病理的理解。方法:根据MeSH术语(自身免疫性肌病、炎症性肌病、特发性炎症性肌病和主要组织相容性复合体和遗传学)的搜索,跟踪本研究的设计、实施、分析和报告。我们为这篇综述文章分析了12篇文章。结论:在IIM的发病机制中,考虑到存在引起免疫反应的触发因素,可以观察到体液免疫和细胞免疫。在免疫遗传学方面,本综述强调了在中国和墨西哥人群中报道的HLADRB1*09:01与DM的存在有关,并且在不同人群中观察到HLADRB1*09:01是第一个发现的变异。这增加了对该等位基因在特殊情况下研究糖尿病的兴趣,并加强了对每个病种实体独立研究IIM的研究。
{"title":"The Etiopathogenesis and Genetic Factors in Idiopathic Inflammatory Myopathies: A Review Article","authors":"Gustavo-Esteban Lugo-Zamudio, Rosa-Elda Barbosa-Cobos, Lucía-Verónica Maya-Piña, Dolores Delgado-Ochoa, María-Mercedes López-Mayorga, Ivonne Arenas-Silva, Diana-Sarai Arellano-Álvarez","doi":"10.2174/18743129-v17-e230327-2022-11","DOIUrl":"https://doi.org/10.2174/18743129-v17-e230327-2022-11","url":null,"abstract":"Introduction: Idiopathic inflammatory myopathies (IIM) are a group of heterogeneous systemic autoimmune diseases characterized by muscle inflammation from unknown causes resulting in chronic weakness. Recent studies have shown the role of the cellular immune response affecting muscle fibers in polymyositis (PM), inclusion body myositis, and to a lesser extent, dermatomyositis (DM), wherein humoral immunity is more involved. The value of genetic factors of the class II major histocompatibility complex (MHC II) has also been highlighted. In studies of murine models, the presence of HLA-DR3 favors a higher risk of developing inflammatory muscle disease, including PM and juvenile DM. In recent years, few studies have provided timely information regarding this, thus the researchers initially proposed a review of existing literature to broaden the context regarding what was described and to visualize proposals that may enhance the understanding of this group of inflammatory pathologies. Methods: The design, implementation, analysis, and reporting of this study were followed according to the search with MeSH terms (Autoimmune myopathy, Inflammatory myopathies, Idiopathic inflammatory myopathies AND Major histocompatibility complex and genetics). We analyzed 12 articles for this review article. Conclusion: In the etiopathogenesis of IIM, both humoral and cellular immunity are observed, considering the presence of a trigger that causes the immune response. As for the immunogenetics, this review highlights what has been reported in Chinese and Mexican populations, where HLADRB1*09:01 is related to the presence of DM, and is observed as the first variant identified in various populations. This increases interest in this allele in the particular case to study DM and strengthens research that proposes the study of IIM independently for each nosological entity.","PeriodicalId":39124,"journal":{"name":"Open Rheumatology Journal","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136005703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
KiOmedine® CM-Chitosan is Effective for Treating Advanced Symptomatic Knee Osteoarthritis up to Six Months Following a Single Intra-Articular Injection: A Post Hoc Analysis of Aproove Clinical Study kiommedine®cm -壳聚糖在单次关节内注射后6个月有效治疗晚期症状性膝骨性关节炎:一项经批准的临床研究事后分析
Q4 Medicine Pub Date : 2023-02-14 DOI: 10.2174/18743129-v16-e220206-2022-19
P.J. Emans, G. Skaliczki, D. Haverkamp, J. Bentin, M. Chausson, M. Schifflers, N. Portelange
Background: Symptomatic knee osteoarthritis (OA) is typically treated with hyaluronan-based intra-articular injections. Advanced knee OA patients are often unresponsive to hyaluronan. KiOmedine ® Carboxymethyl-Chitosan (CM-Chitosan), a novel fluid implant, was safe and effective for treating symptomatic knee OA. Objective: The objective of this study is to describe the efficacy of a single injection of KiOmedine ® CM-Chitosan in advanced knee OA. Methods: Patients with advanced knee OA enrolled in the APROOVE trial and treated with KiOmedine ® CM-Chitosan were identified: subgroup-1, BMI >30 kg/m 2 and/or Kellgren Lawrence (KL) grade III (n=39), and subgroup-2, BMI >30 kg/m 2 and KL-grade III (n=8). Within-group analyses were performed using the WOMAC scores and OMERACT-OARSI responder criteria at 3 and 6 months. Results: In both subgroups, significant improvements in all WOMAC scores were observed at 3 and 6 months (p<0.001 for all comparisons). A high responder rate was observed at 3 and 6 months in subgroup-1 (63.2% and 65.8%) and in subgroup-2 (57.1% and 62.5%). Conclusion: This post hoc analysis of the APROOVE trial showed that a single intra-articular injection with KiOmedine ® CM-Chitosan could be an effective therapeutic option for patients with advanced knee OA. Clinical trial registration number: Clinicaltrial.gov identifier: Net30679208.
背景:症状性膝骨关节炎(OA)通常采用基于透明质酸的关节内注射治疗。晚期膝关节OA患者通常对透明质酸无反应。KiOmedine®羧甲基壳聚糖(cm -壳聚糖)是一种新型液体植入物,安全有效地治疗症状性膝关节炎。目的:本研究的目的是描述单次注射kiommedine®cm -壳聚糖治疗晚期膝关节OA的疗效。方法:纳入aprove试验并接受KiOmedine®cm -壳聚糖治疗的晚期膝关节OA患者被确定为:亚组1,BMI >30 kg/ m2和/或Kellgren Lawrence (KL) III级(n=39),亚组2,BMI >30 kg/ m2和KL- III级(n=8)。在3个月和6个月时使用WOMAC评分和OMERACT-OARSI应答标准进行组内分析。结果:在两个亚组中,在3个月和6个月时观察到所有WOMAC评分的显著改善(p<0.001)。亚组1(63.2%和65.8%)和亚组2(57.1%和62.5%)在3个月和6个月时的应答率较高。结论:aprove试验的事后分析表明,单次关节内注射KiOmedine®cm -壳聚糖可能是晚期膝关节OA患者的有效治疗选择。临床试验注册号:Clinicaltrial.gov标识符:Net30679208。
{"title":"KiOmedine® CM-Chitosan is Effective for Treating Advanced Symptomatic Knee Osteoarthritis up to Six Months Following a Single Intra-Articular Injection: A Post Hoc Analysis of Aproove Clinical Study","authors":"P.J. Emans, G. Skaliczki, D. Haverkamp, J. Bentin, M. Chausson, M. Schifflers, N. Portelange","doi":"10.2174/18743129-v16-e220206-2022-19","DOIUrl":"https://doi.org/10.2174/18743129-v16-e220206-2022-19","url":null,"abstract":"Background: Symptomatic knee osteoarthritis (OA) is typically treated with hyaluronan-based intra-articular injections. Advanced knee OA patients are often unresponsive to hyaluronan. KiOmedine ® Carboxymethyl-Chitosan (CM-Chitosan), a novel fluid implant, was safe and effective for treating symptomatic knee OA. Objective: The objective of this study is to describe the efficacy of a single injection of KiOmedine ® CM-Chitosan in advanced knee OA. Methods: Patients with advanced knee OA enrolled in the APROOVE trial and treated with KiOmedine ® CM-Chitosan were identified: subgroup-1, BMI >30 kg/m 2 and/or Kellgren Lawrence (KL) grade III (n=39), and subgroup-2, BMI >30 kg/m 2 and KL-grade III (n=8). Within-group analyses were performed using the WOMAC scores and OMERACT-OARSI responder criteria at 3 and 6 months. Results: In both subgroups, significant improvements in all WOMAC scores were observed at 3 and 6 months (p<0.001 for all comparisons). A high responder rate was observed at 3 and 6 months in subgroup-1 (63.2% and 65.8%) and in subgroup-2 (57.1% and 62.5%). Conclusion: This post hoc analysis of the APROOVE trial showed that a single intra-articular injection with KiOmedine ® CM-Chitosan could be an effective therapeutic option for patients with advanced knee OA. Clinical trial registration number: Clinicaltrial.gov identifier: Net30679208.","PeriodicalId":39124,"journal":{"name":"Open Rheumatology Journal","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135727534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pancreatitis in systemic lupus erythematosus - case series from a tertiary care center in South India. 系统性红斑狼疮的胰腺炎-来自南印度三级保健中心的病例系列。
Q4 Medicine Pub Date : 2012-01-01 Epub Date: 2012-04-11 DOI: 10.2174/1874312901206010021
Ruchika Goel, Debashish Danda, John Mathew, Ashok Chacko

Unlabelled: Pancreatitis in Systemic Lupus Erythematosus (SLE) is a rare, but life threatening complication. We aimed to study the characteristics and treatment outcome of SLE patients with acute pancreatitis in comparison with those with abdominal pain due to causes other than pancreatitis. Records of SLE patients admitted in our ward with pain abdomen between January 2008 and July 2010 were studied retrospectively. Of 551 SLE in-patients during the study period, 28 (5%) had abdominal pain and 11 (2%) of them were diagnosed to have acute pancreatitis. Five of the 11 patients had severe pancreatitis and 6 had mild pancreatitis. Seizures, arthritis and lack of prior use of steroids were significantly more common in patients with pancreatitis as compared to those with abdominal pain of non pancreatic origin. Seizure occurred more often in severe pancreatitis group as compared to mild pancreatitis. There was no difference in prevalence of lupus anticoagulant and anticardiolipin antibody (40%) between SLE patients with pancreatitis and those with other causes of abdominal pain.

Conclusion: Association of pancreatitis in our cohort of SLE patients include withdrawal of maintenance dose of steroids, seizures and arthritis in univariate analysis. However there was no independent predictor of this complication in our study.

未标示:系统性红斑狼疮(SLE)胰腺炎是一种罕见但危及生命的并发症。我们的目的是研究SLE合并急性胰腺炎患者的特点和治疗结果,并将其与非胰腺炎引起的腹痛患者进行比较。回顾性研究2008年1月至2010年7月间我院收治的伴有腹痛的SLE患者。在研究期间的551例SLE住院患者中,28例(5%)有腹痛,11例(2%)被诊断为急性胰腺炎。11例患者中5例为重度胰腺炎,6例为轻度胰腺炎。与非胰腺源性腹痛患者相比,癫痫发作、关节炎和既往未使用类固醇的患者在胰腺炎患者中更为常见。重症胰腺炎组癫痫发作发生率高于轻度胰腺炎组。狼疮抗凝血剂和抗心磷脂抗体的患病率(40%)在SLE合并胰腺炎患者和其他原因腹痛患者之间没有差异。结论:单因素分析显示,SLE患者中胰腺炎的相关性包括类固醇维持剂量的停药、癫痫发作和关节炎。然而,在我们的研究中没有这种并发症的独立预测因子。
{"title":"Pancreatitis in systemic lupus erythematosus - case series from a tertiary care center in South India.","authors":"Ruchika Goel,&nbsp;Debashish Danda,&nbsp;John Mathew,&nbsp;Ashok Chacko","doi":"10.2174/1874312901206010021","DOIUrl":"https://doi.org/10.2174/1874312901206010021","url":null,"abstract":"<p><strong>Unlabelled: </strong>Pancreatitis in Systemic Lupus Erythematosus (SLE) is a rare, but life threatening complication. We aimed to study the characteristics and treatment outcome of SLE patients with acute pancreatitis in comparison with those with abdominal pain due to causes other than pancreatitis. Records of SLE patients admitted in our ward with pain abdomen between January 2008 and July 2010 were studied retrospectively. Of 551 SLE in-patients during the study period, 28 (5%) had abdominal pain and 11 (2%) of them were diagnosed to have acute pancreatitis. Five of the 11 patients had severe pancreatitis and 6 had mild pancreatitis. Seizures, arthritis and lack of prior use of steroids were significantly more common in patients with pancreatitis as compared to those with abdominal pain of non pancreatic origin. Seizure occurred more often in severe pancreatitis group as compared to mild pancreatitis. There was no difference in prevalence of lupus anticoagulant and anticardiolipin antibody (40%) between SLE patients with pancreatitis and those with other causes of abdominal pain.</p><p><strong>Conclusion: </strong>Association of pancreatitis in our cohort of SLE patients include withdrawal of maintenance dose of steroids, seizures and arthritis in univariate analysis. However there was no independent predictor of this complication in our study.</p>","PeriodicalId":39124,"journal":{"name":"Open Rheumatology Journal","volume":" ","pages":"21-3"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9c/05/TORJ-6-21.PMC3330312.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40179303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
The Frequency of A1298C and C677T Polymorphisms of the Methylentetrahydrofolate Gene in Turkish Patients with Rheumatoid Arthritis: Relationship with Methotrexate Toxicity. 土耳其类风湿性关节炎患者亚甲基四氢叶酸基因A1298C和C677T多态性的频率:与甲氨蝶呤毒性的关系
Q4 Medicine Pub Date : 2011-01-01 Epub Date: 2011-10-14 DOI: 10.2174/1874312901105010030
Ozgür Taşbaş, Pınar Borman, Halil Gürhan Karabulut, Ajlan Tükün, Rezan Yorgancıoğlu

The C677T and A1298C polymorphisms of methylenetatrahydrofolate reductase (MTHFR) gene are reported to have a relationship to methotrexate (MTX) metabolism, with conflicting results. The aim of this study was to determine the frequency of MTHFR C677 T and A1298C gene polymorphisms in a group of Turkish RA patients and evaluate its association with MTX toxicity.Sixty-four patients with RA and 31 control subjects with a mean age of 48.7 ±12.5 and 46.2 ± 13.4 years, were enrolled to the study. Demographic characteristics were obtained and MTX-related adverse effects were recorded in the patient group. The A1298C and C677T polymorphisms of the MTHFR gene were analyzed and the distribution of genotypes according side effects, were determined.The frequency of MTHFR C677T and A1298C polymorphisms were similar in the patient and control groups. Folic acid supplementation with a mean dose of 5mg folic acid/week, was present in all patients. Thirty-six of the 64 patients showed adverse effects to MTX treatment, and MTX had been discontinued in 12 (18.8%) patients due to side effects and/or inefficacy. MTHFR C677T and A1298C gene polymorphisms were found to be similar in patients with and without MTX-related adverse events.In conclusion, A1298C and C677T polymorphisms in the MTHFR gene, were not related with MTX-related toxicity in RA patients receiving folate supplementation. Further studies are needed to illuminate the polymorphisms in other enzymes that might be responsible from the MTX toxicity in patients suffering from RA.

据报道,亚甲基四氢叶酸还原酶(MTHFR)基因C677T和A1298C多态性与甲氨蝶呤(MTX)代谢有关,但结果相互矛盾。本研究的目的是确定一组土耳其类风湿性关节炎患者中MTHFR c677t和A1298C基因多态性的频率,并评估其与MTX毒性的关系。64例RA患者和31例对照组,平均年龄分别为48.7±12.5岁和46.2±13.4岁。获得患者组的人口学特征并记录mtx相关不良反应。分析MTHFR基因的A1298C和C677T多态性,并根据毒副作用确定基因型分布。MTHFR C677T和A1298C多态性的频率在患者和对照组中相似。所有患者均补充平均剂量为5mg /周的叶酸。64例患者中有36例对MTX治疗出现不良反应,其中12例(18.8%)患者因副作用和/或无效而停药。MTHFR C677T和A1298C基因多态性在有无mtx相关不良事件的患者中发现相似。综上所述,MTHFR基因的A1298C和C677T多态性与补充叶酸的RA患者mtx相关毒性无关。需要进一步的研究来阐明可能与风湿性关节炎患者MTX毒性有关的其他酶的多态性。
{"title":"The Frequency of A1298C and C677T Polymorphisms of the Methylentetrahydrofolate Gene in Turkish Patients with Rheumatoid Arthritis: Relationship with Methotrexate Toxicity.","authors":"Ozgür Taşbaş,&nbsp;Pınar Borman,&nbsp;Halil Gürhan Karabulut,&nbsp;Ajlan Tükün,&nbsp;Rezan Yorgancıoğlu","doi":"10.2174/1874312901105010030","DOIUrl":"https://doi.org/10.2174/1874312901105010030","url":null,"abstract":"<p><p>The C677T and A1298C polymorphisms of methylenetatrahydrofolate reductase (MTHFR) gene are reported to have a relationship to methotrexate (MTX) metabolism, with conflicting results. The aim of this study was to determine the frequency of MTHFR C677 T and A1298C gene polymorphisms in a group of Turkish RA patients and evaluate its association with MTX toxicity.Sixty-four patients with RA and 31 control subjects with a mean age of 48.7 ±12.5 and 46.2 ± 13.4 years, were enrolled to the study. Demographic characteristics were obtained and MTX-related adverse effects were recorded in the patient group. The A1298C and C677T polymorphisms of the MTHFR gene were analyzed and the distribution of genotypes according side effects, were determined.The frequency of MTHFR C677T and A1298C polymorphisms were similar in the patient and control groups. Folic acid supplementation with a mean dose of 5mg folic acid/week, was present in all patients. Thirty-six of the 64 patients showed adverse effects to MTX treatment, and MTX had been discontinued in 12 (18.8%) patients due to side effects and/or inefficacy. MTHFR C677T and A1298C gene polymorphisms were found to be similar in patients with and without MTX-related adverse events.In conclusion, A1298C and C677T polymorphisms in the MTHFR gene, were not related with MTX-related toxicity in RA patients receiving folate supplementation. Further studies are needed to illuminate the polymorphisms in other enzymes that might be responsible from the MTX toxicity in patients suffering from RA.</p>","PeriodicalId":39124,"journal":{"name":"Open Rheumatology Journal","volume":" ","pages":"30-5"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1874312901105010030","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40123698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 25
The association of disability and pain with individual and community socioeconomic status in people with hip osteoarthritis. 髋关节骨关节炎患者的残疾和疼痛与个人和社区社会经济地位的关系。
Q4 Medicine Pub Date : 2011-01-01 Epub Date: 2011-10-18 DOI: 10.2174/1874312901105010051
Joshua B Knight, Leigh F Callahan, My-Linh N Luong, Jack Shreffler, Britta Schoster, Jordan B Renner, Joanne M Jordan

Objective: To examine associations between disability and socioeconomic status (SES) in persons with hip radiographic OA (rOA) or symptomatic OA (sxOA) in the Johnston County Osteoarthritis Project.

Methods: Cross-sectional analyses were conducted on individuals with hip rOA (708) or sxOA (251). rOA was defined as Kellgren-Lawrence ≥ 2. Educational attainment (<12 years or ≥12 years) and occupation (managerial or non-managerial) were individual SES measures. Census block group poverty rate (<12%, 12-25%, ≥25%) was the community SES measure. Disability was measured by the HAQ-DI and the WOMAC (function, pain, total). Covariates included age, gender, race, BMI, and presence of knee symptoms. Analyses examined associations of disability with each SES effect separately, followed by multivariable analyses using all SES variables, adjusting for covariates.

Results: In models with single SES variables adjusted for covariates, WOMAC scores were associated significantly (p<0.05) with low educational attainment and non-managerial occupation in rOA and sxOA. HAQ was significantly associated with low educational attainment in rOA and sxOA and with high community poverty in rOA. In models including all SES variables, the patterns of association were similar although with diminished significance. There was indication that education was more strongly associated with HAQ and WOMAC function, while occupation was more strongly associated with WOMAC pain.

Conclusion: Our data provide evidence that individual SES is an important factor to consider when examining disability and pain outcomes in older adults with hip OA.

目的:在约翰斯顿县骨关节炎项目中,研究髋关节放射性骨关节炎(rOA)或症状性骨关节炎(sxOA)患者的残疾与社会经济地位(SES)之间的关系。方法:对髋关节rOA(708例)或sxOA(251例)患者进行横断面分析。rOA定义为kelgren - lawrence≥2。结论:我们的数据提供的证据表明,在检查老年髋关节骨关节炎患者的残疾和疼痛结局时,个体经济地位是一个重要的考虑因素。
{"title":"The association of disability and pain with individual and community socioeconomic status in people with hip osteoarthritis.","authors":"Joshua B Knight,&nbsp;Leigh F Callahan,&nbsp;My-Linh N Luong,&nbsp;Jack Shreffler,&nbsp;Britta Schoster,&nbsp;Jordan B Renner,&nbsp;Joanne M Jordan","doi":"10.2174/1874312901105010051","DOIUrl":"https://doi.org/10.2174/1874312901105010051","url":null,"abstract":"<p><strong>Objective: </strong>To examine associations between disability and socioeconomic status (SES) in persons with hip radiographic OA (rOA) or symptomatic OA (sxOA) in the Johnston County Osteoarthritis Project.</p><p><strong>Methods: </strong>Cross-sectional analyses were conducted on individuals with hip rOA (708) or sxOA (251). rOA was defined as Kellgren-Lawrence ≥ 2. Educational attainment (<12 years or ≥12 years) and occupation (managerial or non-managerial) were individual SES measures. Census block group poverty rate (<12%, 12-25%, ≥25%) was the community SES measure. Disability was measured by the HAQ-DI and the WOMAC (function, pain, total). Covariates included age, gender, race, BMI, and presence of knee symptoms. Analyses examined associations of disability with each SES effect separately, followed by multivariable analyses using all SES variables, adjusting for covariates.</p><p><strong>Results: </strong>In models with single SES variables adjusted for covariates, WOMAC scores were associated significantly (p<0.05) with low educational attainment and non-managerial occupation in rOA and sxOA. HAQ was significantly associated with low educational attainment in rOA and sxOA and with high community poverty in rOA. In models including all SES variables, the patterns of association were similar although with diminished significance. There was indication that education was more strongly associated with HAQ and WOMAC function, while occupation was more strongly associated with WOMAC pain.</p><p><strong>Conclusion: </strong>Our data provide evidence that individual SES is an important factor to consider when examining disability and pain outcomes in older adults with hip OA.</p>","PeriodicalId":39124,"journal":{"name":"Open Rheumatology Journal","volume":" ","pages":"51-8"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cb/9b/TORJ-5-51.PMC3204417.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40123700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 38
Efficacy of transcranial direct current stimulation coupled with a multidisciplinary rehabilitation program for the treatment of fibromyalgia. 经颅直流电刺激结合多学科康复方案治疗纤维肌痛的疗效。
Q4 Medicine Pub Date : 2011-01-01 Epub Date: 2011-10-18 DOI: 10.2174/1874312901105010045
Marcelo Riberto, Fabio Marcon Alfieri, Kátia Monteiro de Benedetto Pacheco, Valeria Dini Leite, Harumi Nemoto Kaihami, Felipe Fregni, Linamara Rizzo Battistella

Unlabelled: Pain control in fibromyalgia patients is limited no matter the therapeutic regimens used. Recent data have shown that daily sessions of anodal transcranial direct current stimulation (tDCS) over the primary motor cortex (M1) in patients with fibromyalgia (FM) are associated with reduction of pain perception.

Objective: We aimed to test whether active tDCS, as compared with sham tDCS, combined with multidisciplinary rehabilitation is associated with significant clinical gains in fibromyalgia.

Design: This was a randomized, double-blinded controlled trial.

Subjects: 23 patients were randomized to receive weekly sessions of multidisciplinary rehabilitation approach combined with sham or anodal tDCS of M1. Patients were evaluated for pain with VAS and for quality of life with SF-36, fibromyalgia pain questionnaire and health assessment questionnaire by a blinded rater before and after the 4 month period of rehabilitation.

Results: Patients tolerated tDCS treatment well, without adverse effects. Patients who received active treatment had a significantly greater reduction of SF-36 pain domain scores (F((2,21))=6.57; p=0.006) and a tendency of higher improvement in Fibromyalgia Impact Questionnaire (FIQ) scores after (p=0.056) as compared with sham tDCS/standard treatment, but no differences were observed in the other domains.

Conclusions: Although active tDCS was associated with superior results in one domain (SF-36 pain domain), the lack of significance in the other domains does not fully support this strategy (weekly tDCS) combined with a multidisciplinary approach.

未标明:纤维肌痛患者的疼痛控制是有限的,无论使用何种治疗方案。最近的数据显示,纤维肌痛(FM)患者每日在初级运动皮质(M1)上进行阳极经颅直流电刺激(tDCS)与疼痛感知的减少有关。目的:我们旨在测试与假tDCS相比,活动tDCS结合多学科康复是否与纤维肌痛的显著临床获益相关。设计:这是一项随机、双盲对照试验。受试者:23例患者随机接受每周一次的多学科康复治疗,并结合M1的假或淋巴结tDCS。采用盲法评估患者康复前后4个月的VAS疼痛、SF-36生活质量、纤维肌痛疼痛问卷和健康评估问卷。结果:患者对tDCS治疗耐受性良好,无不良反应。接受积极治疗的患者SF-36疼痛域评分显著降低(F(2,21))=6.57;p=0.006),与假tDCS/标准治疗相比,纤维肌痛影响问卷(FIQ)评分有更高的改善趋势(p=0.056),但在其他领域无差异。结论:尽管主动tDCS与一个领域(SF-36疼痛领域)的优越结果相关,但在其他领域缺乏意义并不完全支持该策略(每周tDCS)与多学科方法相结合。
{"title":"Efficacy of transcranial direct current stimulation coupled with a multidisciplinary rehabilitation program for the treatment of fibromyalgia.","authors":"Marcelo Riberto,&nbsp;Fabio Marcon Alfieri,&nbsp;Kátia Monteiro de Benedetto Pacheco,&nbsp;Valeria Dini Leite,&nbsp;Harumi Nemoto Kaihami,&nbsp;Felipe Fregni,&nbsp;Linamara Rizzo Battistella","doi":"10.2174/1874312901105010045","DOIUrl":"https://doi.org/10.2174/1874312901105010045","url":null,"abstract":"<p><strong>Unlabelled: </strong>Pain control in fibromyalgia patients is limited no matter the therapeutic regimens used. Recent data have shown that daily sessions of anodal transcranial direct current stimulation (tDCS) over the primary motor cortex (M1) in patients with fibromyalgia (FM) are associated with reduction of pain perception.</p><p><strong>Objective: </strong>We aimed to test whether active tDCS, as compared with sham tDCS, combined with multidisciplinary rehabilitation is associated with significant clinical gains in fibromyalgia.</p><p><strong>Design: </strong>This was a randomized, double-blinded controlled trial.</p><p><strong>Subjects: </strong>23 patients were randomized to receive weekly sessions of multidisciplinary rehabilitation approach combined with sham or anodal tDCS of M1. Patients were evaluated for pain with VAS and for quality of life with SF-36, fibromyalgia pain questionnaire and health assessment questionnaire by a blinded rater before and after the 4 month period of rehabilitation.</p><p><strong>Results: </strong>Patients tolerated tDCS treatment well, without adverse effects. Patients who received active treatment had a significantly greater reduction of SF-36 pain domain scores (F((2,21))=6.57; p=0.006) and a tendency of higher improvement in Fibromyalgia Impact Questionnaire (FIQ) scores after (p=0.056) as compared with sham tDCS/standard treatment, but no differences were observed in the other domains.</p><p><strong>Conclusions: </strong>Although active tDCS was associated with superior results in one domain (SF-36 pain domain), the lack of significance in the other domains does not fully support this strategy (weekly tDCS) combined with a multidisciplinary approach.</p>","PeriodicalId":39124,"journal":{"name":"Open Rheumatology Journal","volume":" ","pages":"45-50"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1874312901105010045","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40123699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 72
期刊
Open Rheumatology Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1